KOSDAQ, 7month 10day morning 807.00points 13.00points higher at the open
KOSDAQ 7month 10day morning 807.00points 13.00opened points higher. On the previous trading day, 7month 9day, it recovered the 800level during trading, while news emerged that Korean American biotech companies 4were considering listing on KOSDAQ and reports continued on collective-intelligence-based new drug development.
KOSDAQ 7month 10day morning 807.00points 13.00opened points higher. The opening came as the previous day's trend continued.
On the previous trading day, 7month 9day, it recovered the 800level during trading, and the closing price ended at 794.00.
Recent reports said that Korean American biotech companies 4were considering or knocking on the door of a KOSDAQ listing.
The report said that Korean bio companies based in the United States are considering raising funds and soliciting domestic investors through listings in South Korea.
Another report said that more companies in South Korea’s pharmaceutical and bio industries are attempting to accelerate new drug development by using a “collective intelligence” approach.
The report on collective intelligence explained that efforts are under way to alter parts of the new drug development process by using external researchers, data, and ideas.
These developments were reported in succession during the same period, along with records of the KOSDAQ’s rises and falls. It was also reported that listing schedules for each company and the scope of collective intelligence applications differ by report.